In case you missed it: June 27 to July 1
A look back at the week's news.
Not just abortion: How the demise of Roe v Wade may impact fertility care
As we were going to press with the July issue, the United States Supreme Court overturned Roe v Wade, eliminating the constitutional right to an abortion, and leaving the question of abortion rights to the states.
Pharmacies limiting Plan B purchases after Roe v. Wade reversal
The American Medical Association is urging the FDA to approve OTC access to oral contraceptives.
HHS secretary details department’s efforts to protect reproductive health care
“The impact was visible and real,” said Xavier Becerra, secretary of the US Department for Health and Human Services during a press conference Tuesday.
SOGH responds to Roe v Wade decision
The Society of Ob/Gyn Hospitalists released a statement on the Supreme Court Decision overturning Roe v Wade.
FDA grants 510(k) clearance to chemiluminescence-based immunoassay
Published: January 10th 2025 | Updated: January 10th 2025The automated chemiluminescence-based immunoassay has received clearance for free testosterone, providing enhanced diagnostic options to a multitude of conditions.
Read More
